Thinking Beyond the Test

The Clinical Laboratory’s Role in Impacting Patient Care

Date: Tuesday, July 26
Time: 7 - 8:30 a.m.
Location: Regency Ballroom CD, Hyatt Regency
Supported by Thermo Fisher Scientific


Protein electrophoresis and IFEs are key to the detection and monitoring of plasma cell dyspraxia. The interpretation of protein and IFE patternsisoften facilitated by the use of software and that is our topic of discussion today. New approaches to myeloma treatment can sometimes alter the presentation of patterns. Strategies for greater accuracy of interpretation and the importance of gauging the efficacy of treatment is another topic to discuss. The Myeloma Tracking software allows for more comprehensive monitoring of treatment in myeloma patients and thus, better outcomes.


After attending this session, participants will be able to:

  • Learn the important points in interpretation of protein and IFE patterns.
  • Understand the implications of new therapies for protein and IFE patterns.
  • Understand the utility of software to monitor the progression of therapy for myeloma patients.


Robert S. Galen, MD, MPH
Professor Emeritus
College of Public Health – University of Georgia
Athens, GA


Douglas Kingma, MD
Medical Director
Tennessee Oncology
Nashville, TN